Favlis Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Panvel, Maharashtra, India, established in 2023.
2023 Panvel, Maharashtra, India Active
Last Updated:
Access Report
About Favlis Pharmaceutical Private Limited

Favlis Pharmaceutical Private Limited, a active private limited company, was established on 06 December 2023 in Panvel, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U21001MH2023PTC415014. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Md Faizan Danish (Director), Md Shahkar Kalam (Director), Mohammad Meraj (Director). Past directors included Mohammad Imran. It is based at C/O Md Aslam,Room No L/13, Kl-1,Cidco Colony,Sec-5/E, Panvel, Maharashtra, 410218.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001MH2023PTC415014

  • Registration Number

    415014

  • Incorporation Date

    06 December 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 2 Months
Company report

Favlis Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Favlis Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Favlis Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Md Faizan Danish Director 06 Dec 2023 Current
Md Shahkar Kalam Director 06 Dec 2023 Current
Mohammad Meraj Director 06 Dec 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Favlis Pharmaceutical.

Enhance accessibility to Favlis Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Favlis Pharmaceutical revenue growth over time
Favlis Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Favlis Pharmaceutical?

Unlock access to Favlis Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Favlis Pharmaceutical?

Unlock and access historical data on people associated with Favlis Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Favlis Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Favlis Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Favlis Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Md Faizan Danish was appointed as a Director was appointed as a Director on 06 Dec 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Md Shahkar Kalam was appointed as a Director was appointed as a Director on 06 Dec 2023 & has been associated with this company since 2 years 2 months . was completed.

  • Director Appointment

    Progress on Mohammad Meraj was appointed as a Director was appointed as a Director on 06 Dec 2023 & has been associated with this company since 2 years 2 months . was documented.

  • Company Incorporation

    The activity Favlis Pharmaceutical Private Limited was registered on 06 Dec 2023 with Roc Mumbai & aged 2 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Favlis Pharmaceutical Private Limited?

The CIN of Favlis Pharmaceutical Private Limited is U21001MH2023PTC415014.

Where is Favlis Pharmaceutical Private Limited headquartered?

Favlis Pharmaceutical Private Limited is headquartered at C/O Md Aslam,Room No L/13, Kl-1,Cidco Colony,Sec-5/E, Panvel, Maharashtra, 410218.

When was Favlis Pharmaceutical Private Limited incorporated?

Favlis Pharmaceutical Private Limited was incorporated on 06 December 2023.

Who are the current directors of Favlis Pharmaceutical Private Limited?

The current directors of Favlis Pharmaceutical Private Limited are

What is the primary industry of Favlis Pharmaceutical Private Limited?

The primary industry of Favlis Pharmaceutical Private Limited is Pharma.

Is Favlis Pharmaceutical Private Limited a listed company?

Favlis Pharmaceutical Private Limited is unlisted.

What is the capital structure of Favlis Pharmaceutical Private Limited?

The authorized capital of Favlis Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available